Meral Kayıkçıoğlu Selected Research

A-Form DNA (A-DNA)

1/2016

Sequencing of mutations in the serine/threonine kinase domain of the bone morphogenetic protein receptor type 2 gene causing pulmonary arterial hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meral Kayıkçıoğlu Research Topics

Disease

4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 06/2011
4	Myocardial Infarction 01/2021 - 11/2014
4	Homozygous Familial Hypercholesterolemia 05/2020 - 10/2014
4	Dyslipidemias (Dyslipidemia) 09/2019 - 04/2017
3	Congenital Heart Defects (Congenital Heart Defect) 10/2021 - 01/2016
3	Pulmonary Arterial Hypertension 10/2021 - 01/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 10/2017
3	Coronary Disease (Coronary Heart Disease) 09/2019 - 06/2011
2	Diabetes Mellitus 07/2021 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2018
2	ST Elevation Myocardial Infarction 11/2020 - 09/2017
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2020 - 04/2017
2	Hypertriglyceridemia 01/2020 - 10/2018
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 09/2019 - 01/2018
2	Peripheral Arterial Disease 09/2019 - 01/2018
2	Hypertension (High Blood Pressure) 12/2018 - 01/2018
2	Hypercholesterolemia 10/2018 - 10/2014
2	Obesity 01/2018 - 03/2017
2	Atherosclerosis 04/2017 - 10/2014
2	Inborn Genetic Diseases (Disease, Hereditary) 04/2017 - 10/2014
1	Gaucher Disease (Gaucher's Disease) 01/2022
1	Pulmonary Hypertension 01/2022
1	Familial Primary Pulmonary Hypertension 10/2021
1	Ischemic Stroke 01/2021
1	Stroke (Strokes) 01/2021
1	Heart Failure 01/2021
1	Non-ST Elevated Myocardial Infarction 11/2020
1	COVID-19 11/2020
1	Myalgia 01/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020
1	Exanthema (Rash) 01/2020
1	Cardiomyopathies (Cardiomyopathy) 01/2019
1	Immunoglobulin Light-chain Amyloidosis 01/2019
1	Amyloidosis 01/2019
1	Insulin Resistance 12/2018
1	Weight Loss (Weight Reduction) 12/2018
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2018
1	Overweight 01/2018
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2018
1	Xanthomatosis (Xanthoma) 10/2017
1	Human Influenza (Influenza) 10/2017
1	Fabry Disease (Fabry's Disease) 09/2017
1	hereditary Thrombophilia 11/2014
1	Carotid Artery Diseases 10/2014
1	Aortic Valve Stenosis (Aortic Stenosis) 10/2014
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 05/2014

Drug/Important Bio-Agent (IBA)

6	CholesterolIBA 01/2020 - 10/2014
6	LipidsIBA 01/2020 - 10/2014
4	oxidized low density lipoproteinIBA 07/2021 - 04/2017
3	LDL CholesterolIBA 07/2021 - 01/2020
3	LDL Lipoproteins (beta Lipoproteins)IBA 05/2020 - 04/2017
3	Triglycerides (Triacylglycerol)IBA 01/2020 - 05/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 12/2018
2	omega-Chloroacetophenone (Mace)IBA 01/2021 - 11/2020
2	EnzymesIBA 01/2020 - 04/2017
2	HDL CholesterolIBA 01/2020 - 10/2018
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 04/2017
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2018 - 01/2018
1	fibrin fragment D (D-dimer)IBA 01/2022
1	C-Reactive ProteinIBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2022
1	SteroidsIBA 01/2022
1	Troponin IIBA 01/2022
1	8-Hydroxy-2'-DeoxyguanosineIBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021
1	SodiumIBA 01/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021
1	Fibric Acids (Fibrates)IBA 01/2020
1	Lipoprotein(a)IBA 01/2020
1	Prealbumin (Transthyretin)IBA 01/2019
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2019
1	Carnitine (L-Carnitine)FDA LinkGeneric 12/2018
1	ApolipoproteinsIBA 12/2018
1	Apolipoproteins B (ApoB)IBA 12/2018
1	Blood Glucose (Blood Sugar)IBA 12/2018
1	DNA (Deoxyribonucleic Acid)IBA 05/2018
1	AnticoagulantsIBA 10/2017
1	7-(N-(3-aminopropyl)amino)heptan-2-oneIBA 10/2017
1	GlycosphingolipidsIBA 09/2017
1	Lipoproteins (Lipoprotein)IBA 04/2017
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 01/2016
1	A-Form DNA (A-DNA)IBA 01/2016
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2016
1	Factor V (Coagulation Factor V)IBA 11/2014
1	Ventricular MyosinsIBA 05/2014
1	Interleukin-10 (Interleukin 10)IBA 06/2011

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2018
3	Blood Component Removal (Apheresis) 05/2020 - 10/2014
3	Secondary Prevention 09/2019 - 01/2018
2	Treatment Delay 11/2020 - 10/2014
2	Percutaneous Coronary Intervention 11/2020 - 12/2018
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 12/2018 - 09/2010
1	Cardiopulmonary Resuscitation (CPR) 09/2019
1	Thrombolytic Therapy 09/2017
1	Enzyme Replacement Therapy 09/2017